Cite
MLA Citation
Keisuke Nakamura et al.. “A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19.” Clinical and translational science, vol. 15, no. 11, 2022, pp. 2697–2708. http://access.bl.uk/ark:/81055/vdc_100169750722.0x000019